Effects of empagliflozin on serum uric acid level of patients with type 2 diabetes mellitus: a systematic review and meta-analysis.

"Declarations Ethics approval and consent to participateThis research is written according to Preferred reporting items for systematic review and meta-analysis [25], and its protocol was registered on the PROSPERO website (CRD42023438793). Consent for publicationI, the undersigned, give my consent for the publication of identifiable details, which can include photograph(s) and/or and/or details within the text (“Material”) to be published in the above Journal and Article. Competing interestsThe authors declare that there is no conflict of interest. Competing interests The authors declare that there is no conflict of interest."

"Funding Not applicable."

"The present study investigated the effect of empagliflozin treatment on SUA using the systematic review method and meta-analysis. This research is written according to Preferred reporting items for systematic review and meta-analysis [], and its protocol was registered on the PROSPERO website (CRD42023438793). Declarations: Ethics approval and consent to participateThis research is written according to Preferred reporting items for systematic review and meta-analysis [25], and its protocol was registered on the PROSPERO website (CRD42023438793).: Consent for publicationI, the undersigned, give my consent for the publication of identifiable details, which can include photograph(s) and/or and/or details within the text (“Material”) to be published in the above Journal and Article.: Competing interestsThe authors declare that there is no conflict of interest. Ethics approval and consent to participate: This research is written according to Preferred reporting items for systematic review and meta-analysis [25], and its protocol was registered on the PROSPERO website (CRD42023438793)."